These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35713981)
1. Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease. Ye Y; Zhang X; Li T; Ma J; Wang R; Wu C; Wang R; Bao C; Ye S; Shen N; Guo Q; Fu Q; Zhang X Arthritis Rheumatol; 2022 Nov; 74(11):1822-1832. PubMed ID: 35713981 [TBL] [Abstract][Full Text] [Related]
2. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis. Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240 [TBL] [Abstract][Full Text] [Related]
3. Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease. Li X; Liu Y; Cheng L; Huang Y; Yan S; Li H; Zhan H; Li Y J Clin Lab Anal; 2022 Nov; 36(11):e24726. PubMed ID: 36221983 [TBL] [Abstract][Full Text] [Related]
4. Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis. Takada T; Aoki A; Asakawa K; Sakagami T; Moriyama H; Narita I; Sato S Respir Med; 2015 Sep; 109(9):1174-80. PubMed ID: 26187000 [TBL] [Abstract][Full Text] [Related]
5. Clinical features and immune-related protein patterns of anti-MDA5 positive clinically amyopathic dermatomyositis Dutch patients. Hensgens MPM; Delemarre EM; Drylewicz J; Voortman M; Krol RM; Dalm VASH; Miedema JR; Wiertz I; Grutters J; Limper M; Nierkens S; Leavis HL Rheumatology (Oxford); 2022 Oct; 61(10):4087-4096. PubMed ID: 35048953 [TBL] [Abstract][Full Text] [Related]
6. Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease. Xu L; You H; Wang L; Lv C; Yuan F; Li J; Wu M; Da Z; Wei H; Yan W; Zhou L; Yin S; Zhou D; Wu J; Lu Y; Su D; Liu Z; Liu L; Ma L; Xu X; Zang Y; Liu H; Ren T; Wang F; Du Y; Xue J; Zhang M; Tan W Arthritis Rheumatol; 2023 Apr; 75(4):609-619. PubMed ID: 35849805 [TBL] [Abstract][Full Text] [Related]
7. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies. Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268 [TBL] [Abstract][Full Text] [Related]
8. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies. Asakawa K; Yoshizawa K; Aoki A; Kimura Y; Tanaka T; Ohashi K; Hayashi M; Kikuchi T; Sato S; Takada T Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068 [TBL] [Abstract][Full Text] [Related]
9. Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease: The FLAIR Model. Lian X; Zou J; Guo Q; Chen S; Lu L; Wang R; Zhou M; Fu Q; Ye Y; Bao C Chest; 2020 Oct; 158(4):1535-1545. PubMed ID: 32428508 [TBL] [Abstract][Full Text] [Related]
10. Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody. Takada T; Ohashi K; Hayashi M; Asakawa K; Sakagami T; Kikuchi T; Sato S Respir Med; 2018 Aug; 141():7-13. PubMed ID: 30053975 [TBL] [Abstract][Full Text] [Related]
11. Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome. Zuo Y; Ye L; Chen F; Shen Y; Lu X; Wang G; Shu X Front Immunol; 2022; 13():845988. PubMed ID: 35320936 [TBL] [Abstract][Full Text] [Related]
12. Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease. Xu A; Ye Y; Fu Q; Lian X; Chen S; Guo Q; Lu LJ; Dai M; Lv X; Bao C Rheumatology (Oxford); 2021 Jul; 60(7):3343-3351. PubMed ID: 33331866 [TBL] [Abstract][Full Text] [Related]
13. Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis. So H; Wong VTL; Lao VWN; Pang HT; Yip RML Clin Rheumatol; 2018 Jul; 37(7):1983-1989. PubMed ID: 29713969 [TBL] [Abstract][Full Text] [Related]
14. Tumor markers are associated with rapidly progressive interstitial lung disease in adult-dermatomyositis. Wang Q; Gao C; Zhang C; Yao M; Liang W; Sun W; Zheng Z Clin Rheumatol; 2022 Jun; 41(6):1731-1739. PubMed ID: 35138465 [TBL] [Abstract][Full Text] [Related]
15. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split? Ikeda S; Arita M; Morita M; Ikeo S; Ito A; Tokioka F; Noyama M; Misaki K; Notohara K; Ishida T BMC Pulm Med; 2015 Dec; 15():159. PubMed ID: 26651481 [TBL] [Abstract][Full Text] [Related]
16. Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient. Li ZY; Gill E; Mo F; Reyes C BMC Pulm Med; 2020 Aug; 20(1):220. PubMed ID: 32799827 [TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease. Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718 [TBL] [Abstract][Full Text] [Related]
18. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD. Horiike Y; Suzuki Y; Fujisawa T; Yasui H; Karayama M; Hozumi H; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Ogawa N; Suda T Rheumatology (Oxford); 2019 Dec; 58(12):2143-2152. PubMed ID: 31143953 [TBL] [Abstract][Full Text] [Related]
19. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease. Ye Y; Fu Q; Wang R; Guo Q; Bao C J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087 [TBL] [Abstract][Full Text] [Related]
20. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis. Xu Y; Yang CS; Li YJ; Liu XD; Wang JN; Zhao Q; Xiao WG; Yang PT Clin Rheumatol; 2016 Jan; 35(1):113-6. PubMed ID: 26660480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]